AK Medical Holdings Limited

HKEX:1789.HK

5.6 (HKD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Revenue 689.275662.35435.525677.817513.175453.348313.808447.633556.407478.979488.922437.783325.555275.007210.183162.517155.43115.347103.082103.08251.54174.13937.07
Cost of Revenue 279.562260.688182.639258.219225.158164.434122.952139.3178.198142.656150.25133.204107.48384.19858.09650.81447.99635.4732.05432.05416.02723.46711.733
Gross Profit 409.713401.663252.886419.598288.017288.914190.856308.333378.209336.323338.672304.579218.072190.809152.087111.703107.43479.87771.02871.02835.51450.67325.336
Gross Profit Ratio 0.5940.6060.5810.6190.5610.6370.6080.6890.680.7020.6930.6960.670.6940.7240.6870.6910.6920.6890.6890.6890.6830.683
Reseach & Development Expenses 75.63164.08369.26669.30455.63546.42561.33251.73761.07443.945.39335.13426.0319.56517.03417.92912.1248.2669.4399.4394.727.773.885
General & Administrative Expenses 71.64172.30852.76869.45256.00246.54254.2851.03644.75638.2643.98347.5638.49135.63436.94618.27619.22118.89416.01516.0158.0089.6394.819
Selling & Marketing Expenses 127.904113.00791.824108.47470.59485.097108.62678.72191.35162.7590.92784.40772.68550.19230.73719.6622.13114.0983.8613.8611.9311.6250.813
SG&A 199.545186.795142.089201.226136.549131.64162.906129.757136.107101.01134.91131.967111.17685.82667.68337.93641.35232.99219.87619.8769.93811.2645.632
Other Expenses -13.750000000000-1.873-1.873000-0.6705.2355.2352.6172.7441.372
Operating Expenses 261.426250.878211.356270.53192.185167.594217.291180.722205.01144.591179.712151.609134.948104.56385.45954.06551.42341.32834.5534.5517.27521.77710.889
Operating Income 148.287150.78541.531149.06995.832115.078-29.483128.919185.418192.356165.86137.47885.3685.86768.19657.69255.66937.70134.98237.97618.98830.14915.074
Operating Income Ratio 0.2150.2280.0950.220.1870.254-0.0940.2880.3330.4020.3390.3140.2620.3120.3240.3550.3580.3270.3390.3680.3680.4070.407
Total Other Income Expenses Net 9.01113.03730.01316.014-6.33212.4696.432.693-5.6824.515-0.90718.9711.1872.086-0.9820.4780.6690.9882.9940000
Income Before Tax 157.298163.82271.544165.08389.5127.548-23.053131.612179.736196.871164.953156.44986.54787.95367.21458.1756.33838.68937.97637.97618.98830.14915.074
Income Before Tax Ratio 0.2280.2470.1640.2440.1740.281-0.0730.2940.3230.4110.3370.3570.2660.320.320.3580.3620.3350.3680.3680.3680.4070.407
Income Tax Expense 22.62523.45723.08726.55511.91919.9884.18920.12928.63427.51626.89413.00316.56111.8888.1212.2345.4675.5225.5222.7614.2882.144
Net Income 134.673140.36548.456138.52877.581107.56-18.864111.483151.136162.871137.437129.55573.54471.39255.32650.0544.10433.22232.45432.45416.22725.86112.93
Net Income Ratio 0.1950.2120.1110.2040.1510.237-0.060.2490.2720.340.2810.2960.2260.260.2630.3080.2840.2880.3150.3150.3150.3490.349
EPS 0.120.140.0430.1290.070.094-0.020.10.130.150.130.120.070.0690.070.0670.0560.0440.0330.0320.0160.0260.013
EPS Diluted 0.120.130.0430.120.0690.094-0.0170.10.140.150.130.120.070.0690.0720.0670.0590.0440.0330.0320.0160.0260.013
EBITDA 177.597194.06487.145195.373134.772149.966-8.547165.399203.001218.375181.141152.39796.68493.56274.07663.45860.25541.43937.37540.52120.2632.4116.205
EBITDA Ratio 0.2580.2930.20.2880.2630.331-0.0270.3690.3650.4560.370.3480.2970.340.3520.390.3880.3590.3630.3930.3930.4370.437